EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer

Xueqi Ou, Yeru Tan, Jindong Xie, Jingping Yuan, Xinpei Deng, Ruonan Shao, Cailu Song, Xi Cao, Xiaoming Xie, Rongfang He, Yuehua Li, Hailin Tang

Drug Resistance Updates · 2024-03 · 73 · 101063

DOI: 10.1016/j.drup.2024.101063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2024-03. Verfasst von Xueqi Ou und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 156-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: This study aims to explore the function and mechanism of G Protein-coupled receptor class C group 5 member A (GPRC5A) in docetaxel-resistance and liver metastasis of breast cancer. METHODS: Single-cell RNA transcriptomic analysis and bioinformatic analysis are used to screen relevant genes in breast cancer metastatic hepatic specimens. MeRIP, dual-luciferase analysis and bioinformation were used to detect m6A modulation. Mass spectrometry (MS), co-inmunoprecipitation (co-IP) and immunofluorescence colocalization were executed to explore the mechanism of GPRC5A in breast cancer cells. RESULT: GPRC5A was upregulated in triple-negative breast cancer (TNBC) and was associated with a poor prognosis. In vitro and in vivo experiments demonstrated that knockdown of GPRC5A alleviated metastasis and resistance to docetaxel in TNBC. Overexpression of GPRC5A had the opposite effects. The m6A methylation of GPRC5A mRNA was modulated by METTL3 and YTHDF1, which facilitates its translation. GPRC5A inhibited the ubiquitination-dependent degradation of LAMTOR1, resulting in the recruitment of mTORC1 to lysosomes and activating the mTORC1/p70s6k signaling pathway. CONCLUSION: METTL3/YTHDF1 axis up-regulates GPRC5A expression by m6A methylation. GPRC5A activates mTORC1/p70s6k signaling pathway by recruiting mTORC1 to lysosomes, consequently promotes docetaxel-resistance and liver metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsLiver NeoplasmsHumansDocetaxelRibosomal Protein S6 Kinases, 70-kDaSignal TransductionMethylationReceptors, G-Protein-CoupledTOR Serine-Threonine KinasesMechanistic Target of Rapamycin Complex 1Methyltransferases

Stichwörter der Autor:innen

Docetaxel resistanceLiver metastasisMTORN6-methyladenosine modulationTriple negative breast cancer

Substanzen

DocetaxelRibosomal Protein S6 Kinases, 70-kDaReceptors, G-Protein-CoupledTOR Serine-Threonine KinasesMechanistic Target of Rapamycin Complex 1GPRC5A protein, humanMETTL3 protein, humanMethyltransferases

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China.
  • Department of Pathology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China. Electronic address: herongfang2019@fsyy.usc.edu.cn.
  • The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China. Electronic address: liyuehua2020@stu.usc.edu.cn.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. Electronic address: tanghl@sysucc.org.cn.

Zitieren

APA

Ou, X., Tan, Y., Xie, J., Yuan, J., Deng, X., Shao, R., Song, C., Cao, X., Xie, X., He, R., Li, Y., & Tang, H. (2024). Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer. Drug Resistance Updates, 73, 101063. https://doi.org/10.1016/j.drup.2024.101063

Vancouver

Ou X, Tan Y, Xie J, Yuan J, Deng X, Shao R, et al. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer. Drug Resistance Updates. 2024;73:101063. doi:10.1016/j.drup.2024.101063

BibTeX
@article{Ou2024,
  author = {Ou, Xueqi and Tan, Yeru and Xie, Jindong and Yuan, Jingping and Deng, Xinpei and Shao, Ruonan and Song, Cailu and Cao, Xi and Xie, Xiaoming and He, Rongfang and Li, Yuehua and Tang, Hailin},
  title = {Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer},
  journal = {Drug Resistance Updates},
  year = {2024},
  volume = {73},
  pages = {101063},
  doi = {10.1016/j.drup.2024.101063}
}
Kostenlos starten →